Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.68 |
| ▸ | IDO1 | P14902 | 5/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.54 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.52 |
| ▸ | HTR3B | O95264 | 1/20 | 0.52 |
| ▸ | HTR3A | P46098 | 1/20 | 0.52 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.52 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | DAO | P14920 | 2/20 | 0.50 |
| ▸ | AGXT | P21549 | 2/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | IGF1R | P08069 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | GFER | P55789 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8196751 | 0.88 | SIGMAR1 (0.58) | TAAR1LMNAMAOBALOX15 | |
| SCHEMBL16663974 | 0.88 | TAAR1 (0.56) | TAAR1IDO1LMNACYP2A6MAOB | |
| SCHEMBL10365734 | 0.87 | IGF1R (0.64) | TAAR1IDO1LMNACYP2A6MAOB | |
| SCHEMBL18050371 | 0.87 | TAAR1 (0.62) | TAAR1IDO1LMNACYP2A6MAOB | |
| SCHEMBL18550393 | 0.86 | TAAR1 (0.54) | TAAR1IDO1LMNAMAOBAOC3 | |
| SCHEMBL8584816 | 0.86 | TAAR1 (0.54) | TAAR1IDO1LMNACYP2A6MAOB | |
| SCHEMBL12809556 | 0.86 | CNR2 (0.55) | TAAR1IDO1CYP2A6MAOBAOC3 | |
| SCHEMBL5647781 | 0.86 | ESR1 (0.74) | TAAR1HTR3AIGF1RALOX15GFER | |
| Ammonia Solution, Strong SCHEMBL11188168 | 0.86 | SIGMAR1 (0.56) | TAAR1LMNAMAOBALOX15 | |
| SCHEMBL16663705 | 0.86 | TAAR1 (0.54) | TAAR1IDO1MAOBAOC3HTR3E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912606-A | Catalyst suitable for ethylene polymerization reaction and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119263950-A | Synthesis method of 1, 2-bis (4-vinyl phenyl) ethane | 上海康鹏科技股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-117264211-A | Low-melting-point polyarylene sulfide resin and film, and preparation methods and applications thereof | 新凝合科技(成都)有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-119263950-A | Synthesis method of 1, 2-bis (4-vinyl phenyl) ethane | 上海康鹏科技股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-117567331-A | Synthesis method of 1, 2-dithioethane compound and 1, 4-dithiane | 河北北方学院 | 2024-02-20 | — | — | CN | disclosed |
| CN-117264211-A | Low-melting-point polyarylene sulfide resin and film, and preparation methods and applications thereof | 新凝合科技(成都)有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-11773045-B2 | Acid-catalyzed photocatalyzed oxidation reaction of benzylic C—H bonds of aromatic compound | NANJING TECH UNIVERSITY (CN) | 2023-10-03 | — | — | US | disclosed |
| US-20230242470-A1 | ACID-CATALYZED PHOTOCATALYZED OXIDATION REACTION OF BENZYLIC C-H BONDS OF AROMATIC COMPOUND | NANJING TECH UNIVERSITY (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | H. LUNDBECK A/S (DK) | 2023-07-13 | — | — | US | disclosed |
| CN-114507109-B | Method for synthesizing bibenzyl compound by photocatalysis | 苏州大学张家港工业技术研究院 | 2023-06-23 | — | — | CN | disclosed |
| US-11655217-B2 | Pyrazole MAGL inhibitors | H. LUNDBECK A/S (DK) | 2023-05-23 | — | — | US | disclosed |
| WO-2010117285-A2 | PROCESS FOR THE PREPARATION OF GRIGNARD COMPOUNDS | ZAKLADY FARMACEUTYCZNE POLPHARMA SA (PL) | 2010-10-14 | — | — | WO | disclosed |
| EP-1861376-A1 | CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS | F. Hoffmann-Roche AG (CH) | 2007-12-05 | — | — | EP | disclosed |
| US-7304103-B2 | One step; high functionality; maintains critical properties; polymer composite materials, molecular electronics, sensor devices | WILLIAM MARSH RICE UNIVERSITY (US) | 2007-12-04 | — | — | US | disclosed |
| WO-2006097261-A1 | CIS-2,4,5-TRIARYL-IMIDAZOLINES AND THEIR USE AS ANTI-CANCER MEDICAMENTS | F.HOFFMANN-LA ROCHE AG (CH) | 2006-09-21 | — | — | WO | disclosed |
| EP-1458677-A1 | 3-PHENYL-2-ARYLALKYLTHIOPROPIONIC ACID DERIVATIVES AS SELECTIVE AGONISTS OF PPAR-ALPHA | Astrazeneca AB (SE) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003051826-A1 | 3-PHENYL-2-ARYLALKYLTHIOPROPIONIC ACID DERIVATIVES AS SELECTIVE AGONISTS OF PPAR-ALPHA | ASTRAZENECA AB (SE) | 2003-06-26 | — | — | WO | disclosed |
| US-5093046-A | Suppression of dimerization | BASF AKTIENGESELLSCHAFT (DE) | 1992-03-03 | — | — | US | disclosed |
| EP-0415247-A2 | Process for the preparation of ether solutions of arylmethylmagnesium halides | BASF Aktiengesellschaft (DE) | 1991-03-06 | — | — | EP | disclosed |
| US-4585594-A | CARBONYLATION OF ALLYL ALCOHOL DERIVATIVE | BASF AKTIENGESELLSCHAFT (DE) | 1986-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219897-A1 | PYRAZOLE MAGL INHIBITORS | MGLL, PNLIP, LPL | TAAR1 2957/4885IDO1 3336/4885LMNA 2986/4885 |
| US-11655217-B2 | Pyrazole MAGL inhibitors | MGLL, PNLIP, LPL | TAAR1 2850/4885IDO1 3331/4885LMNA 3058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.